Matches in Wikidata for { <http://www.wikidata.org/entity/Q59333826> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q59333826 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59333826 description "wetenschappelijk artikel" @default.
- Q59333826 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q59333826 name "1407. Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS)" @default.
- Q59333826 name "1407. Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System" @default.
- Q59333826 type Item @default.
- Q59333826 label "1407. Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS)" @default.
- Q59333826 label "1407. Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System" @default.
- Q59333826 prefLabel "1407. Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS)" @default.
- Q59333826 prefLabel "1407. Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System" @default.
- Q59333826 P1433 Q59333826-FC6DD129-92DA-4CFE-9556-C4167FDFD0FE @default.
- Q59333826 P1476 Q59333826-A3B15EA1-5AF3-4108-8A71-14F2171839FE @default.
- Q59333826 P2093 Q59333826-28F4AEF5-366A-4D88-A429-D84526B3ED56 @default.
- Q59333826 P2093 Q59333826-CBE8A595-07BD-4167-B251-A47E91E8F846 @default.
- Q59333826 P2093 Q59333826-DD30024A-299E-407D-9C5A-B01092BC98C4 @default.
- Q59333826 P275 Q59333826-70101cf4-b06f-4382-8211-a03af03cd9b1 @default.
- Q59333826 P304 Q59333826-A321D447-1473-48E9-92F5-CF9E5DACB87B @default.
- Q59333826 P31 Q59333826-385C8B86-B7CE-4E8F-A811-3E09EBAA725D @default.
- Q59333826 P356 Q59333826-173E5157-983E-4C53-BE8A-D3F356693BB6 @default.
- Q59333826 P433 Q59333826-4CF955C9-BD0A-46F8-B6F9-42AD8DCB997E @default.
- Q59333826 P478 Q59333826-B2795EDC-A4CD-4306-A206-C0C4CCAFCD44 @default.
- Q59333826 P577 Q59333826-41A4BDCA-EA9E-4AEF-853F-EB46E0C52ACB @default.
- Q59333826 P6216 Q59333826-8362aeae-6106-43d9-917c-4c75ee353b78 @default.
- Q59333826 P932 Q59333826-5FE209FB-BB7B-4A80-A93A-D5C78BDED1B3 @default.
- Q59333826 P356 OFY210.1238 @default.
- Q59333826 P1433 Q27725953 @default.
- Q59333826 P1476 "1407. Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS)" @default.
- Q59333826 P2093 "Emily Spivak" @default.
- Q59333826 P2093 "Jesse Sutton" @default.
- Q59333826 P2093 "Tristan T Timbrook" @default.
- Q59333826 P275 Q24082749 @default.
- Q59333826 P304 "S433-S433" @default.
- Q59333826 P31 Q13442814 @default.
- Q59333826 P356 "10.1093/OFID/OFY210.1238" @default.
- Q59333826 P433 "suppl_1" @default.
- Q59333826 P478 "5" @default.
- Q59333826 P577 "2018-11-01T00:00:00Z" @default.
- Q59333826 P6216 Q50423863 @default.
- Q59333826 P932 "6254277" @default.